[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer].
Paillard MJ, Curtit E, Dobi E, Mansi L, Bazan F, Villanueva C, Chaigneau L, Montcuquet P, Meneveau N, Thiery-Vuillemin A, Nerich V, Pivot X.
Paillard MJ, et al.
Bull Cancer. 2015 Sep;102(9):737-48. doi: 10.1016/j.bulcan.2015.03.021. Epub 2015 May 26.
Bull Cancer. 2015.
PMID: 26022285
French.